Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesStemsation International Inc

Stemsation International Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.0118 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
2000
Market Cap
10.67M

Momentum Score

…

Stemsation International, Inc. researches, develops, manufactures, and sells canned and flavored oxygen products in the United States. The company sells its products through business to business and direct to consumers channels. Stemsation International, Inc. was incorporated in 2006 and is headquartered in Plantation, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.00
Low
0.02
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Stemsation International Inc (ticker STSN) is limited and filings provide few operational details, so the company's core activities and product lines are not well documented. Because key disclosures are sparse, long-term growth drivers cannot be reliably identified; investors seeking microcap exposure may view potential upside but should be cautious given the information shortfall.
Key investment risks include thin trading liquidity and high volatility typical of PINK-listed microcaps, possible absence of audited financial statements and robust corporate governance, and heightened risk of dilutive financings or regulatory delisting.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.14
ROE
-
Net Debt
1.50M
ROCE
-3.56%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.46M -0.90M -0.09M -0.30M -0.34M
Net income -0.46M -0.90M -0.09M -0.44M -1.15M
Ebit - - -0.06M -0.29M -0.17M
Ebitda -0.39M -0.85M 0.11M -0.06M 0.06M
Depreciation and amortization - - 0.17M 0.23M 0.24M
Operating income -0.39M -0.85M -0.07M -0.06M -0.17M
Other operating expenses 0.39M 0.85M 0.08M 0.06M 0.17M
Interest expense 0.07M 0.05M 0.02M 0.24M 0.17M
Income tax expense - - -0.17M 0.14M 0.81M
Total operating expenses 0.39M 0.85M 0.08M 0.06M 0.17M
Total other income expense net -0.07M -0.05M -0.00M -0.24M -0.17M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 12.99M 12.99M 0.04M 0.06M 0.08M
Other current assets 0.38M 0.38M 0.04M 0.05M 0.07M
Total liab 1.99M 1.53M 0.73M 0.91M 0.98M
Total stockholder equity 10.99M 11.46M -0.68M -0.85M -0.90M
Other current liab 0.49M 0.36M 0.36M 0.36M 0.63M
Common stock 0.06M 0.06M 0.03M 0.02M 0.02M
Retained earnings -6.60M -6.14M -5.24M -5.15M -4.71M
Cash 0.00M 0.00M 0.00M 0.01M 0.01M
Total current liabilities 1.99M 1.53M 0.73M 0.91M 0.91M
Net debt 1.50M 1.08M 0.28M 0.45M 0.21M
Short term debt 1.50M 1.09M 0.28M 0.46M 0.21M
Short long term debt total 1.50M 1.09M 0.28M 0.46M 0.21M
Other stockholder equity 17.52M 17.52M 4.52M 4.27M 3.79M
Total current assets 0.39M 0.39M 0.04M 0.06M 0.08M
Net receivables - - - - 0.00M
Accounts payable - 0.09M 0.08M 0.09M 0.07M
Accumulated other comprehensive income 0.01M 0.01M 0.01M 0.00M 0.00M
Non current assets total 12.60M 12.60M - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities - -0.34M - - -
Total cash from financing activities 0.35M 0.80M 0.04M 0.07M 0.16M
Net income -0.46M -0.90M -0.09M -0.30M -1.15M
Change in cash -0.00M 0.00M -0.01M -0.00M -0.60M
Begin period cash flow 0.00M 0.00M 0.01M 0.01M 0.02M
End period cash flow 0.00M 0.00M 0.00M 0.01M -0.58M
Total cash from operating activities -0.36M -0.45M -0.05M -0.07M -0.77M
Other cashflows from investing activities - -0.34M -0.00M - -
Change to inventory - - - - 0.00M
Change to account receivables - - - 0.00M -0.00M
Other cashflows from financing activities - - 0.00M 0.00M 0.00M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.03M 0.00M -0.00M 0.13M 0.25M
Other non cash items 0.07M 0.44M 0.04M 0.10M 0.14M
Free cash flow -0.36M -0.45M -0.05M -0.07M -0.77M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
STSN
Stemsation International Inc		 -
-%		 0.01 - - 727.92 - 2056.99 -26.47
MKKGY
Merck KGaA ADR		 -0.74
2.19%		 33.06 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -
-%		 170.05 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.34
1.66%		 21.18 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.72 - 10.66 0.01 1.16 2.94 23.11

Profile*

Stemsation International Inc

Stemsation International, Inc. researches, develops, manufactures, and sells canned and flavored oxygen products in the United States. The company sells its products through business to business and direct to consumers channels. Stemsation International, Inc. was incorporated in 2006 and is headquartered in Plantation, Florida.

1537 NW 65th Avenue, Plantation, FL, United States, 33313

609-221-9200

https://www.stsninc.com

Name Title Year Born
Mr. Ray C. Carter Jr. Founder, CEO & Pres NA
Dr. Mira Gadzala Ph.D. Chief Science Officer NA
Ms. Svetlana Nedkovska Managing Director of Europe NA
Mr. Nicholas B. Panza Sec. NA
Mr. Ray C. Carter Jr. Founder, CEO & President NA
Mr. Nicholas B. Panza Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…